Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| CytomX Therapeutics, Inc. | 3,244,381 | reported | 29 Nov 2016 | tx 34+4,898,755−5,525,129 |
| Celldex Therapeutics, Inc. | 83,212 | reported | 04 Jun 2014 | tx 13+29,000 |
| TRANS1 INC | 68,400 | reported | 02 Jan 2014 | tx 1+52,500 |
| NextCure, Inc. | 22,000 | reported | 13 Jun 2019 | tx 10+2,276,442−17,710,060 |
| IDEAYA Biosciences, Inc. | 16,200 | reported | 07 Jun 2023 | tx 10+2,720,913−2,260,713 |
| ARVINAS, INC. | 10,192 | reported | 16 Jun 2022 | tx 40+5,060,103−16,628,980 |
| Rallybio Corp | 6,041 | reported | 03 Jan 2022 | tx 7+2,429,193−14,854,276 |
| CURAGEN CORP | 0 | reported | 01 Oct 2009 | tx 14+1,499,616−2,622,480 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 07 Jun 2023 | GRANT_AWARD | IDEAYA Biosciences, Inc. | 16,200 | 0.00 USD | deriv |
| 16 Jun 2022 | GRANT_AWARD | ARVINAS, INC. | 10,192 | 0.00 USD | deriv |
| 09 Jun 2022 | GRANT_AWARD | IDEAYA Biosciences, Inc. | 11,000 | 0.00 USD | deriv |
| 03 Jan 2022 | GRANT_AWARD | Rallybio Corp | 6,041 | 0.00 USD | deriv |
| 23 Aug 2021 | SALE | ARVINAS, INC. | 1,599 | 88.01 USD | |
| 24 Aug 2021 | SALE | ARVINAS, INC. | 4,568 | 86.95 USD | |
| 24 Aug 2021 | SALE | ARVINAS, INC. | 4,635 | 87.08 USD | |
| 25 Aug 2021 | SALE | ARVINAS, INC. | 14,267 | 85.03 USD | |
| 01 Sept 2021 | SALE | ARVINAS, INC. | 29,478 | 86.79 USD | |
| 02 Sept 2021 | SALE | ARVINAS, INC. | 23,316 | 86.34 USD | |
| 01 Sept 2021 | SALE | ARVINAS, INC. | 18,821 | 85.67 USD | |
| 31 Aug 2021 | SALE | ARVINAS, INC. | 12,189 | 86.21 USD | |
| 31 Aug 2021 | SALE | ARVINAS, INC. | 47,166 | 85.39 USD | |
| 01 Sept 2021 | SALE | ARVINAS, INC. | 19,275 | 87.86 USD | |
| 01 Sept 2021 | SALE | ARVINAS, INC. | 11,863 | 88.59 USD | |
| 02 Sept 2021 | SALE | ARVINAS, INC. | 28,449 | 85.42 USD | |
| 07 Sept 2021 | SALE | ARVINAS, INC. | 5,467 | 88.90 USD | |
| 07 Sept 2021 | SALE | ARVINAS, INC. | 14,163 | 90.08 USD | |
| 07 Sept 2021 | SALE | ARVINAS, INC. | 2,030 | 90.75 USD | |
| 03 Sept 2021 | SALE | ARVINAS, INC. | 2,319 | 86.39 USD | |
| 07 Sept 2021 | SALE | ARVINAS, INC. | 14,751 | 87.98 USD | |
| 03 Sept 2021 | SALE | ARVINAS, INC. | 30,068 | 85.47 USD | |
| 30 Aug 2021 | SALE | ARVINAS, INC. | 1,181 | 88.22 USD | |
| 30 Aug 2021 | SALE | ARVINAS, INC. | 7,581 | 87.51 USD | |
| 30 Aug 2021 | SALE | ARVINAS, INC. | 25,469 | 86.40 USD |
2 purchases reported after at least 12 months of silence — most recent on 02 Aug 2021.